Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
This intro outlines practical zero based budgeting essentials, helping you assign every dollar to a purpose and track progress toward your goals.
20,497 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
CoreWeave’s latest trading session highlighted the tension between high-growth AI clouds and the realities of funding...
Thirty-five donor families pledged $1.03 billion to multi-year initiatives across the U.S. and beyond, a landmark dis...
As 2026 unfolds, a value-led rotation is drawing fresh money into the Vanguard Value ETF (VTV). With inflation coolin...
This article breaks down Summit Hotel (Inn) earnings, translating quarterly results into actionable insights for inve...
In January 2026, retirees commonly see smaller Social Security checks even after a cost-of-living adjustment, as high...
DraftKings chief executive clarifies that bets tied to wars or deaths won’t be offered, even as the company pivots to...
A major manager disclosed a sizable stake reduction in BXP, prompting questions about the outlook for Class A office ...
SpaceX is lining up a blockbuster IPO that could outpace the entire 2025 IPO slate. Analysts estimate a multi-billion...
Lucid’s stock once rode a wave of excitement in the EV space, but it has cooled dramatically. This guide breaks down ...
Powell's warning to Wall Street is shaping market expectations as AI optimism runs high. This article breaks down wha...
As KVHI gears up for the 2025 earnings call, investors should focus on revenue drivers, margins, and long-term strate...